MaxCyte, Inc.
MXCT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7 | $9 | $10 | $9 |
| % Growth | -19.7% | -18.1% | 19.5% | – |
| Cost of Goods Sold | $1 | $2 | $1 | $2 |
| Gross Profit | $6 | $7 | $9 | $6 |
| % Margin | 92.4% | 82.1% | 85.6% | 73.8% |
| R&D Expenses | $5 | $6 | $6 | $5 |
| G&A Expenses | $6 | $8 | $9 | $7 |
| SG&A Expenses | $10 | $14 | $14 | $14 |
| Sales & Mktg Exp. | $4 | $6 | $6 | $6 |
| Other Operating Expenses | $2 | $1 | $1 | $1 |
| Operating Expenses | $17 | $21 | $21 | $19 |
| Operating Income | -$11 | -$14 | -$12 | -$13 |
| % Margin | -154.8% | -167.2% | -118.3% | -148.4% |
| Other Income/Exp. Net | -$2 | $2 | $2 | $2 |
| Pre-Tax Income | -$12 | -$12 | -$10 | -$11 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$12 | -$10 | -$11 |
| % Margin | -181.8% | -145.3% | -98.8% | -121.9% |
| EPS | -0.12 | -0.12 | -0.1 | -0.1 |
| % Growth | 0% | -20% | 0% | – |
| EPS Diluted | -0.12 | -0.12 | -0.1 | -0.1 |
| Weighted Avg Shares Out | 106 | 106 | 106 | 105 |
| Weighted Avg Shares Out Dil | 106 | 106 | 106 | 105 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $2 | $2 | $2 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $2 |
| EBITDA | -$12 | -$13 | -$11 | -$11 |
| % Margin | -169.4% | -152% | -106% | -130.8% |